The latest research report by Emergen Research, named ‘Global Tumor Genomics Market - Forecast to 2028’, involves a thorough analysis of the current and projected market trends for tumour genomics worldwide. The study compiles useful data on the most well-known market participants, sales and distribution channels, regional spectrum, anticipated market share and size, and revenue projections for the anticipated year.
Additionally, improvements in computational methods for tumour genomics have led to quicker results, which is a major element in boosting uptake and, ultimately, market expansion. However, next generation sequencing techniques have aided researchers in gathering enormous volumes of tumour genomic data and recording genetic abnormalities in many cancer types. Tumors are frequently caused by genetic modifications, including gene fusions and significant chromosomal rearrangements.
Get a sample of the report @ https://www.emergenresearch.com/request-sample/531
Global Tumor Genomics Market Geographical Landscape - Synopsis:
- The report closely studies the growth trajectory of the global Tumor Genomics market. It brings to light the global dominance of the leading regional segments, including North America, Asia Pacific, Europe, Latin America, and the Middle East Africa.
- The study elaborates on the crucial information pertaining to the regional market share. It simultaneously focuses on the significant details about the growth patterns of each regional market.
- Moreover, the report encases an exhaustive geographical study of the market, emphasizing the business growth prospects and market barriers for each of the key market regions.
Key companies profiled in the report include:
Thermo Fisher Scientific Inc.,
Illumina, Inc.,
QIAGEN,
Agilent Technologies, Inc.,
Bio-Rad Laboratories, Inc.,
- Hoffmann-La Roche Ltd.,
Merck KGaA,
Pacific Biosciences of California, Inc.,
NeoGenomics Laboratories, Inc.,
Myriad Genetics, Inc., and
PerkinElmer
Key Highlights of Report
- In September 2018, Cancer Genetics Inc. and NovellusDx Ltd. signed a merger agreement in order to combine their data associated to tumor anatomy. The aim behind the merger is to enhance and accelerate the therapeutic development to improve treatment success rates for companies. With the proprietary technology and machine learning technology of NovellusDX Ltd., Cancer Genetics aims to form a leading oncology-focused precision medicine company.
- Biomarkers play an important role in the detection of cancer and it may be used to detect early cancer symptoms or to perform differential diagnosis of cancerous tumors.
To know more about the report, visit @ https://www.emergenresearch.com/industry-report/tumor-genomics-market
The report further covers comprehensive SWOT analysis and Porter’s Five Forces analysis to offer a complete understanding of the competitive landscape and scenario of each market player. The report also provides an in-depth analysis of the applications and product types offered in the market.
Emergen Research has segmented the global tumor genomic market on the basis of technique, application, end-use, and region:
Technique Outlook (Revenue, USD Billion; 2021–2028)
- Next Generation Sequencing Technique (NGS)
- Polymerase Chain Reaction (PCR)
- Microarray
- In-Situ Hybridization (ISH)
- Immunohistochemistry (ICH)
- Others (Mass Spectrometry and Flow Cytometry)
Application Outlook (Revenue, USD Billion; 2021–2028)
- Diagnostics and Monitoring
- Drug Discovery and Development
- Biomarker Discovery
End-use Outlook (Revenue, USD Billion; 2021–2028)
- Academics and Research Organizations
- Hospitals and Ambulatory Clinics
- Clinical and Diagnostic Laboratories
- Biotechnology and Pharmaceutical Company
To get customization of the report @ https://www.emergenresearch.com/request-for-customization/531
Thank you for reading our report. Please get in touch with us for further queries about the report and our team will assist you according to your needs.
To know more about the Emergen research reports
Automotive Airbag Silicone Market
Insulating Glass Window Market
About Us:
Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyse consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Contact Us:
Eric Lee
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com
Visit for More Insights: https://www.emergenresearch.com/insights
Explore Our Custom Intelligence services | Growth Consulting Services
